Filing Details
- Accession Number:
- 0001645627-17-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-23 13:14:55
- Reporting Period:
- 2017-05-19
- Filing Date:
- 2017-05-23
- Accepted Time:
- 2017-05-23 13:14:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,906,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,907,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,908,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,909,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-19 | 1,000 | $0.05 | 20,910,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,911,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,912,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,913,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,914,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,915,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,916,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.05 | 20,917,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,918,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,919,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,920,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,921,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,922,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,923,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,924,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,925,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,926,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,927,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,000 | $0.06 | 20,928,249 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
